Evaluation of efficacy and sedative profiles of H1 antihistamines by large-scale surveillance using the visual analogue scale (VAS)

Allergology International

Volumn 57, Issue 3, 2008, Pages 257-263

  Izumi, Norimasa ^a   Mizuguchi, Hiroyuki ^a   Umehara, Hayato ^a   Ogino, Satoshi ^b   Fukui, Hiroyuki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Antihistamines; Efficacy; Questionnaire; Sleepiness; Visual analogue scale

Indexed keywords

BETOTASTINE; CETIRIZINE; CLEMASTINE; DEXCHLORPHENIRAMINE MALEATE; EBASTINE; EPINASTINE; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; LORATADINE; MEQUITAZINE; OLOPATADINE;

ADOLESCENT; ADULT; AGED; ALLERGY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEPTOR OCCUPANCY; SCHOOL CHILD; SEDATION; SIDE EFFECT; VISUAL ANALOG SCALE;

EID: 53749084552     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-07-525     Document Type: Article

References (22)

1. Goldberg MJ, Spector R, Chiang CK. Transport of diphenhydramine in the central nervous system. J Pharmacol Exp Ther 1987; 240:717-22.
2. Adelsberg BR. Sedation and performance issues in the treatment of allergic conditions. Arch Intern Med 1997; 157:494-500.
3. Yanai K, Ryu JH, Watanabe T et al. Positron emission tomographic study of central histamine H1-receptor occupancy in human subjects treated with epinastine, a second-generation antihistamine. Methods Find Exp Clin Pharmacol 1995;17:64-9.
4. Yanai K, Ryu JH, Watanabe T et al. Histamine H1 receptor occupancy in human brain after single oral dose of histamine H1 antagonists measured by Positron emission tomography. Br J Pharmacol 1995; 116:l649-55.
5. Yanai K, Okumura N, Tagawa M, Itoh M, Watanabe T. New findings in pharmacological effects induced by antihistamines: from PET studies to knock-out mice. Clin Exp Allergy 1999;29:29-36; discussion 37-8.
6. Tagawa M, Kano M, Okinnura N et al. Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation, antihistamine, and (+)-chlorpheniramine, a classical antihistamine. Br J Clin Pharmacol 2001;52:501-9.
7. Yanai K,, Tashiro M. The physiological and pathophysiological roles of neuronal histamine: An insight from human positron emission tomography studies. Pharmacol Ther 2007;113:1-15.
8. Shamsi Z, Hindmarch I. Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios. Hum Psychopharmacol 2000;15:S3-S30.
9. Hindmarch I, Shamsi Z, Kimber S. An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers. Clin Exp Allergy 2002;32:133-9.
10. Femandez E, Turk DC. Sensory and affective components of pain: separation and synthesis. Psychol Bull 1992; 112: 205-17.
11. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scale. J Rheumatol 1982;9:189-96.
12. Ehrs PO, Berg H, Larsson K. Quality of life in primary care asthma. Respir Med 2001;95:22-30.
13. Ng KH, Chong D, Wong CK et al. Central nervous system side effects of first- and second-generation antihistamines in school children with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled comparative study. Pediatrics 2004; 113:116-21.
14. Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog Neurobiol 2001;63:637-72.
15. Haas H, Panula P. The role of histamine and the tubero-mamillary nucleus in the nervous system. Nat Rev Neurosci 2003;4:121-30.
16. Eigenmann PA, Zamora SA. An intetnet-based survey on the circumstances of food-induced reactions following the diagnosis of IgE-mediated food allergy. Allergy 2002;57: 449-53.
17. Uguz A, Lack G, Pumphrey R et al. Allergic reactions in the community: a questionnaire survey of members of the anaphylaxis campaign. Clin Exp Allergy 2005;35:746-50.
18. Assanasen P, Naclerio RM. Antiallergic anti-inflammatory effects of H1-antihistamines in humans. Clin Allergy Immunol 2002; 17:101-39.
19. Drescher S, Schaeffeler E, Hitzl M et al. MDR1 gene polymorphism and disposition of the P-glycoprotein substrate fexofenadine. Br J Clin Pharmacol 2002;53:526-34.
20. Del Cuvillo A, Mullol J, Bartra J et al. Comparative pharmacology of the H1 antihistamines. J Investig Allergol Clin Immunol 2006; 16:3-12.
21. Simons FE, Simons KJ. The pharmacology and use of H1-receptor-antagonist drugs. N Exgl J Med 1994;330:1663-70.
22. Takahashi H, Ishida-Yamamoto A, Iizuka H. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance. Clin Exp Dermatol 2004; 29:526-32.